Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.9 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |
mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.9 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |